Active	Status	Sponsor type	Region	Phase	Filter
1 Active 1 Inactive 2 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other Show only owner-sponsored trials	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

1 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
ABvac40 / Grifols
NCT03461276 / 2016-004352-30: Safety and Immunogenicity of Repeated Doses of ABvac40 in Patients With a-MCI or Vm-AD	Completed	2	134	Europe	ABvac40, Placebo	Araclon Biotech S.L.	Mild Cognitive Impairment, Alzheimer Disease	03/23	03/23